Herceptin News and Research

RSS
Renowned biotech researcher to receive TJU's Lennox K. Black International Prize

Renowned biotech researcher to receive TJU's Lennox K. Black International Prize

Grove professor to investigate personalized therapies against breast cancer

Grove professor to investigate personalized therapies against breast cancer

Trastuzumab increases risk of heart failure in older women with breast cancer

Trastuzumab increases risk of heart failure in older women with breast cancer

FDA grants Priority Review to ImmunoGen’s trastuzumab emtansine BLA

FDA grants Priority Review to ImmunoGen’s trastuzumab emtansine BLA

Adding angiogenesis inhibitor to anti-HER2 drugs extends survival in mice with breast cancer

Adding angiogenesis inhibitor to anti-HER2 drugs extends survival in mice with breast cancer

LRRK2 inhibitors may provide neuroprotection for patients with Parkinson's

LRRK2 inhibitors may provide neuroprotection for patients with Parkinson's

OS data from ImmunoGen's trastuzumab emtansine Phase III trial on breast cancer

OS data from ImmunoGen's trastuzumab emtansine Phase III trial on breast cancer

Research focuses on HER2 cancers

Research focuses on HER2 cancers

Genomes of lung cancer smokers have more mutations

Genomes of lung cancer smokers have more mutations

Predicting breast cancer drug response by 20/20 GeneSystems’ PredicTOR test

Predicting breast cancer drug response by 20/20 GeneSystems’ PredicTOR test

Obesity and breast cancer recurrence: an interview with Dr. Joseph Sparano

Obesity and breast cancer recurrence: an interview with Dr. Joseph Sparano

Herceptin® (trastuzumab) delivery methods: an interview with Dr Gustavo Ismael

Herceptin® (trastuzumab) delivery methods: an interview with Dr Gustavo Ismael

Results from Roche's trastuzumab emtansine Phase III trial on HER2-positive breast cancer

Results from Roche's trastuzumab emtansine Phase III trial on HER2-positive breast cancer

Herceptin® could potentially be delivered via a standard injection

Herceptin® could potentially be delivered via a standard injection

Researchers discover reason why breast cancer cells become drug resistant

Researchers discover reason why breast cancer cells become drug resistant

Study demonstrates effectiveness of combination therapy for breast cancer cells in vitro

Study demonstrates effectiveness of combination therapy for breast cancer cells in vitro

Genentech's Perjeta helps people with HER2-positive metastatic breast cancer live longer

Genentech's Perjeta helps people with HER2-positive metastatic breast cancer live longer

ImmunoGen reports data from T-DM1 Phase III trial on HER2-positive metastatic breast cancer

ImmunoGen reports data from T-DM1 Phase III trial on HER2-positive metastatic breast cancer

Study supports wider testing for immune-based therapies to treat advanced non-small cell lung cancer

Study supports wider testing for immune-based therapies to treat advanced non-small cell lung cancer

Personalized medicine and the Human Genome Project

Personalized medicine and the Human Genome Project